{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:03:07Z","timestamp":1771401787830,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["No. 2023YFF0613403"],"award-info":[{"award-number":["No. 2023YFF0613403"]}]},{"name":"Beijing Research Ward Excellence Program","award":["No. BRWEP2024W032150206"],"award-info":[{"award-number":["No. BRWEP2024W032150206"]}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["No. PX2024038"],"award-info":[{"award-number":["No. PX2024038"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["No. Y-Young2023-0286"],"award-info":[{"award-number":["No. Y-Young2023-0286"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06772-0","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:29:54Z","timestamp":1768886994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global burden of non-Hodgkin lymphoma in the elderly: a population-based study using GBD 2021"],"prefix":"10.1007","volume":"105","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-1411","authenticated-orcid":false,"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"3","key":"6772_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/PPO.0000000000000451","volume":"26","author":"L de Leval","year":"2020","unstructured":"de Leval L, Jaffe ES (2020) Lymphoma classification. Cancer J 26(3):176\u2013185","journal-title":"Cancer J"},{"key":"6772_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.puhe.2023.11.023","volume":"226","author":"Z Shen","year":"2024","unstructured":"Shen Z, Tan Z, Ge L et al (2024) The global burden of lymphoma: estimates from the global burden of disease 2019 study. Public Health 226:199\u2013206","journal-title":"Public Health"},{"key":"6772_CR3","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021[J]. Lancet (London, England) (2024) 403(10440): 2133\u20132161"},{"issue":"7","key":"6772_CR4","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.18632\/aging.204006","volume":"14","author":"W Liu","year":"2022","unstructured":"Liu W, Liu J, Song Y et al (2022) Burden of lymphoma in China, 1990\u20132019: an analysis of the global burden of diseases, injuries, and risk factors study 2019. Aging 14(7):3175\u20133190","journal-title":"Aging"},{"issue":"3","key":"6772_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Cancer J Clin 74(3):229\u2013263","journal-title":"Cancer J Clin"},{"issue":"7","key":"6772_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","volume":"7","author":"GBD 2019 Colorectal Cancer Collaborators","year":"2022","unstructured":"GBD 2019 Colorectal Cancer Collaborators (2022) Global, regional, and national burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. The Lancet. Gastroenterology & Hepatology 7(7):627\u2013647","journal-title":"The Lancet. Gastroenterology & Hepatology"},{"key":"6772_CR7","doi-asserted-by":"crossref","unstructured":"Yang K, Yang X, Jin C et al (2024) Global burden of type 1 diabetes in adults aged 65 years and older, 1990\u20132019: population based study[J]. BMJ 385:e078432","DOI":"10.1136\/bmj-2023-078432"},{"issue":"10258","key":"6772_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2019 Demographics Collaborators","year":"2020","unstructured":"GBD 2019 Demographics Collaborators (2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet (London, England) 396(10258):1160\u20131203","journal-title":"Lancet (London, England)"},{"issue":"1","key":"6772_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05728-9","volume":"25","author":"S Liang","year":"2025","unstructured":"Liang S, Xi SZ, Liu JY et al (2025) Global burden and cross-country inequalities of nutritional deficiencies in adults aged 65 years and older, 1990\u20132021: population-based study using the GBD 2021. BMC Geriatr 25(1):74","journal-title":"BMC Geriatr"},{"issue":"10258","key":"6772_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet (London, England) 396(10258):1204\u20131222","journal-title":"Lancet (London, England)"},{"issue":"29","key":"6772_CR11","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R et al (2009) Estimating average annual per cent change in trend analysis[J]. Stat Med 28(29):3670\u20133682","journal-title":"Stat Med"},{"issue":"7","key":"6772_CR12","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/1055-9965.EPI-11-0421","volume":"20","author":"PS Rosenberg","year":"2011","unstructured":"Rosenberg PS, Anderson WF (2011) Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 20(7):1263\u20131268","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"11","key":"6772_CR13","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF (2014) A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 23(11):2296\u20132302","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6772_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.07.003","author":"B Wu","year":"2024","unstructured":"Wu B, Li Y, Shi B et al (2024) Temporal trends of breast cancer burden in the western Pacific region from 1990 to 2044: implications from the global burden of disease study 2019. J Adv Res 59:189\u2013199. https:\/\/doi.org\/10.1016\/j.jare.2023.07.003","journal-title":"J Adv Res"},{"issue":"10011","key":"6772_CR15","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/S0140-6736(15)00150-6","volume":"386","author":"M Marmot","year":"2015","unstructured":"Marmot M (2015) The health gap: the challenge of an unequal world. Lancet 386(10011):2442\u20132444","journal-title":"Lancet"},{"issue":"3","key":"6772_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/geronb\/gbab055","volume":"77","author":"WJJ Yeung","year":"2022","unstructured":"Yeung WJJ, Lee Y (2022) Aging in east Asia: new findings on retirement, health, and well-being. J Gerontol B Psychol Sci Soc Sci 77(3):589\u2013591","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"6","key":"6772_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR et al (2016) 2016 US lymphoid malignancy statistics by world health organization subtypes[J]. Cancer J Clin 66(6):443\u2013459","journal-title":"Cancer J Clin"},{"issue":"10","key":"6772_CR18","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/annonc\/mdx342","volume":"28","author":"F Islami","year":"2017","unstructured":"Islami F, Chen W, Yu XQ et al (2017) Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. Annals of Oncology: Official Journal of the European Society for Medical Oncology 28(10):2567\u20132574","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"9","key":"6772_CR19","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/ijc.33369","volume":"148","author":"F Saberi Hosnijeh","year":"2021","unstructured":"Saberi Hosnijeh F, Casabonne D, Nieters A et al (2021) Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: an exposome-wide analysis[J]. Int J Cancer 148(9):2115\u20132128","journal-title":"Int J Cancer"},{"issue":"8","key":"6772_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/aje\/kwp018","volume":"169","author":"DB Richardson","year":"2009","unstructured":"Richardson DB, Sugiyama H, Wing S et al (2009) Positive associations between ionizing radiation and lymphoma mortality among men[J]. Am J Epidemiol 169(8):969\u2013976","journal-title":"Am J Epidemiol"},{"issue":"6","key":"6772_CR21","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/ijc.32977","volume":"147","author":"S Naudin","year":"2020","unstructured":"Naudin S, Solans Margalef M, Saberi Hosnijeh F et al (2020) Healthy lifestyle and the risk of lymphoma in the European prospective investigation into cancer and nutrition study[J]. Int J Cancer 147(6):1649\u20131656","journal-title":"Int J Cancer"},{"issue":"1","key":"6772_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00684-x","volume":"14","author":"T Pan","year":"2025","unstructured":"Pan T, Zhang J, Wang X et al (2025) Global burden and trends of hematologic malignancies based on global cancer observatory 2022 and global burden of disease 2021. Exp Hematol Oncol 14(1):98","journal-title":"Exp Hematol Oncol"},{"issue":"13","key":"6772_CR23","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1080\/10428194.2019.1613538","volume":"60","author":"R P\u00e1lmarsd\u00f3ttir","year":"2019","unstructured":"P\u00e1lmarsd\u00f3ttir R, Kiesbye \u00d8vlisen A, Severinsen MT et al (2019) Socioeconomic impact of hodgkin lymphoma in adult patients: a systematic literature review[J]. Leuk Lymphoma 60(13):3116\u20133131","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"6772_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17228705","volume":"17","author":"Q Guo","year":"2020","unstructured":"Guo Q, Luo K, Hu R (2020) The spatial correlations of health resource agglomeration capacities and their influencing factors: evidence from China. Int J Environ Res Public Health 17(22):8705","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"6772_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood-2018-03-839035","volume":"132","author":"JS Goldstein","year":"2018","unstructured":"Goldstein JS, Nastoupil LJ, Han X et al (2018) Disparities in survival by insurance status in follicular lymphoma[J]. Blood 132(11):1159\u20131166","journal-title":"Blood"},{"issue":"8","key":"6772_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2019000847","volume":"135","author":"J Kline","year":"2020","unstructured":"Kline J, Godfrey J, Ansell SM (2020) The immune landscape and response to immune checkpoint blockade therapy in lymphoma. Blood 135(8):523\u2013533","journal-title":"Blood"},{"issue":"11","key":"6772_CR27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00247-019-04529-8","volume":"49","author":"KM McCarten","year":"2019","unstructured":"McCarten KM, Nadel HR, Shulkin BL et al (2019) Imaging for diagnosis, staging and response assessment of hodgkin lymphoma and non-hodgkin lymphoma[J]. Pediatr Radiol 49(11):1545\u20131564","journal-title":"Pediatr Radiol"},{"issue":"5","key":"6772_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.21147\/j.issn.1000-9604.2019.05.02","volume":"31","author":"W Liu","year":"2019","unstructured":"Liu W, Zhu J (2019) Comments on Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (english version). Chin J Cancer Res 31(5):738\u2013739","journal-title":"Chin J Cancer Res"},{"key":"6772_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06559-9","author":"T Li","year":"2025","unstructured":"Li T, Liang X, Lin B et al (2025) The global, regional, and national burden of non-hodgkin lymphoma in 204 countries and territories and 811 subnational locations, 1990\u20132021: an update from the global burden of disease study 2021. Ann Hematol 104(11):5783\u20135796. https:\/\/doi.org\/10.1007\/s00277-025-06559-9","journal-title":"Ann Hematol"},{"issue":"5","key":"6772_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R et al (2018) Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health 6(5):e555-e567","journal-title":"Lancet Glob Health"},{"key":"6772_CR31","doi-asserted-by":"publisher","first-page":"1056030","DOI":"10.3389\/fonc.2022.1056030","volume":"12","author":"Y Yao","year":"2022","unstructured":"Yao Y, Liu H, Zhao F et al (2022) Age-period-cohort analysis of gender differential trends in incidence and mortality of non-hodgkin lymphoma in China, 1990\u20132019[J]. Front Oncol 12:1056030","journal-title":"Front Oncol"},{"issue":"5","key":"6772_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","volume":"142","author":"MP Chao","year":"2010","unstructured":"Chao MP, Alizadeh AA, Tang C et al (2010) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-hodgkin lymphoma[J]. Cell 142(5):699\u2013713","journal-title":"Cell"},{"issue":"1","key":"6772_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0743-4","volume":"12","author":"P Gao","year":"2019","unstructured":"Gao P, Lazare C, Cao C et al (2019) Immune checkpoint inhibitors in the treatment of virus-associated cancers. J Hematol Oncol 12(1):58","journal-title":"J Hematol Oncol"},{"issue":"2","key":"6772_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11864-021-00925-1","volume":"23","author":"AM Bock","year":"2022","unstructured":"Bock AM, Nowakowski GS, Wang Y (2022) Bispecific antibodies for non-Hodgkin lymphoma treatment. Curr Treat Options Oncol 23(2):155\u2013170","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"6772_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/cam4.3686","volume":"10","author":"Z Ying","year":"2021","unstructured":"Ying Z, Yang H, Guo Y et al (2021) Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed\/refractory large B-cell lymphoma in China[J]. Cancer Med 10(3):999\u20131011","journal-title":"Cancer Med"},{"issue":"4","key":"6772_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH et al (2022) Polatuzumab Vedotin in previously untreated diffuse large B-cell lymphoma[J]. N Engl J Med 386(4):351\u2013363","journal-title":"N Engl J Med"},{"issue":"10438","key":"6772_CR37","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(23)02705-8","volume":"403","author":"E Silkenstedt","year":"2024","unstructured":"Silkenstedt E, Salles G, Campo E et al (2024) B-cell non-Hodgkin lymphomas. Lancet 403(10438):1791\u20131807","journal-title":"Lancet"},{"issue":"27","key":"6772_CR38","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin Oncology: Official J Am Soc Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06772-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:39Z","timestamp":1771398219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06772-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6772"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06772-0","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not require ethical approval due to the publicly available data used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}